¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"progressive unilateral facial atrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • progressive cardiomyopathic lentiginosis
    ÁøÇà½É±Ùº´Èæ»öÁ¡Áõ
  • progressive case
    ÁøÇ༺¿¹
  • progressive deafness
    ÁøÇ೭û
  • progressive diaphyseal dysplasia
    ÁøÇ༺»À¸öÅëÇü¼ºÀÌ»ó, ÁøÇ༺°ñ°£Çü¼ºÀÌ»ó
  • progressive diffuse keratoderma
    ±¤¹üÀ§ÁøÇà°¢ÁúÇǺÎÁõ
  • progressive disseminated histoplasmosis
    ÁøÇàÆÄÁ¾È÷½ºÅäÇö󽺸¶Áõ
  • progressive external ophthalmoplegia
    ÁøÇà¹Ù±ù´«±ÙÀ°¸¶ºñ
  • progressive hypertrophic interstitial neuritis
    ÁøÇàºñ´ë»çÀÌÁú½Å°æ¿°, ÁøÇàºñ´ë°£Áú½Å°æ¿°
  • progressive lingual hemiatrophy
    ÁøÇàÇô¹ÝÀ§ÃàÁõ
  • progressive mean
    ´©°¡Æò±Õ
  • progressive multifocal leukoencephalopathy
    ÁøÇà´ÙÃÊÁ¡¹é(»ö)Áú³úº´(Áõ)
  • progressive muscular dystrophy
    ÁøÇà±Ù(À°)µð½ºÆ®·ÎÇÇ
  • progressive myopia
    ÁøÇà±Ù½Ã
  • progressive nuclear ophthalmoplegia
    ÁøÇà½Å°æÇÙ´«±ÙÀ°¸¶ºñ
  • progressive outer retinal necrosis
    ÁøÇ༺¿Ü¸Á¸·±«»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • essential progressive deafness
    Ư¹ßÁøÇ೭û
  • progressive deafness
    ÁøÇ೭û
  • progressive diaphyseal dysplasia
    ÁøÇà»À¸öÅëÇü¼ºÀÌ»ó, ÁøÇà°ñ°£Çü¼ºÀÌ»ó
  • progressive muscular dystrophy
    ÁøÇà±ÙÀ°ÅðÇàÀ§Ãà
  • progressive pigmentary dermatosis
    ÁøÇà»ö¼ÒÇǺκ´
  • progressive resistance exercise
    Á¡ÁõÀúÇ׿
  • progressive subcortical encephalopathy
    ÁøÇà°ÑÁú¹Ø³úº´Áõ
  • familial progressive hearing loss
    °¡Á·ÁøÇ೭û
  • rapidly progressive glomerulonephritis
    ±Þ¼ÓÁøÇàÅ丮ÄáÆÏ¿°, ±Þ¼ÓÁøÇà»ç±¸Ã¼½Å¿°
  • malignant progressive histiocytoma
    ¾Ç¼ºÁøÇàÁ¶Á÷±¸Á¾
  • progressive disseminated histoplasmosis
    ÁøÇàÆÄÁ¾È÷½ºÅäÇö󽺸¶Áõ
  • progressive lingual hemiatrophy
    ÁøÇàÇô¹ÝÀ§ÃàÁõ
  • progressive diffuse keratoderma
    ±¤¹üÀ§ÁøÇà°¢ÁúÇǺÎÁõ
  • progressive cardiomyopathic lentiginosis
    ÁøÇà½ÉÀå±ÙÀ°º´Èæ»öÁ¡Áõ
  • progressive multifocal leukoencephalopathy
    ÁøÇà´ÙÃÊÁ¡¹é»öÁú³úÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • infantile muscular atrophy =Werdnig-Hoffmann disease
    ¿µ¾ÆÇü ±ÙÀ§ÃàÁõ(?ä®û¡ÐÉê×õêñø).
  • peroneal muscular atrophy
    ºñ°ñ±Ù À§ÃàÁõ(ÝëÍéÐÉê×õêñø).
  • pigmentary atrophy
    »ö¼Ò¼º À§Ãà(ßäáÈàõ ê×õê)
  • postinflammatory optic atrophy
    ¿°ÁõÈĽýŰæÀ§Ãà
  • postneuritic optic atrophy
    ¿°ÁõÈĽýŰæÀ§Ãà
  • pressure atrophy
    ¾Ð¹ÚÀ§Ãà(äâÚÞê×õê).
  • primary optic atrophy
    ¿ø¹ß½Ã½Å°æÀ§Ãà(ê«Û¡ãÊãêÌèê×õê).
  • primary optic atrophy
    ¿ø¹ß(¼º) ½Ã½Å°æÀ§Ãà(ê«Û¡(àõ) ãÊãêÌèê×õê)
  • red atrophy
    Àû»öÀ§Ãà(îåßäê×õê)
  • renal atrophy
    ½ÅÀ§Ãà(ãìê×õê).
  • renal atrophy
    ½ÅÀ§Ãà(ãìê×õê)
  • renal atrophy
    ½ÅÀ§Ãà
  • acquired progressive lymphangioma
    ÈÄõ¼º ÁøÇ༺ ¸²ÇÁ°üÁ¾
  • hereditary progressive mucinous histiocytosis X
    À¯Àü¼º ÁøÇ༺ Á¡¾×¼ºÁ¶Á÷±¸Áõ
  • progressive
    ÁøÇ༺
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • familial progressive hyperpigmentatio
    °¡Á·¼º ÁøÇ༺ °ú»ö¼ÒÁõ.
  • familial progressive hyperpigmentation
    °¡Á·¼º ÁøÇ༺ °ú»ö¼ÒÄ§Âø
  • familial progressive sensorineural
    °¡Á·¼º ÁøÇà(¼º)
  • hereditary progressive mucinous histiocytosis X
    À¯Àü¼º ÁøÇ༺ Á¡¾×¼ºÁ¶Á÷±¸Áõ
  • keratosis extremitatum progrediens => progressive diffuse keratoderma
  • leukoencephalopathy,progressive multifocal
    º´Áõ(Ü»ñø)
  • malignant progressive histiocytoma
    ¾Ç¼º ÁøÇ༺ Á¶Á÷±¸Á¾
  • multiple progressive angioma
    ´Ù¹ß¼º ÁøÇ༺ Ç÷°üÁ¾
  • progressive
    ÁøÇ༺
  • progressive
    ÁøÇ༺ÀÇ(òäú¼àõ¡­), Á÷Áø(¼º)ÀÇ(òÁòä(àõ)¡­)
  • progressive bulbar palsy
    ÁøÇ༺ ±¸<¿¬¼ö>¸¶ºñ(òäú¼àõϹ<æÅâÐ> Ýö).
  • progressive cardiomyopathic lentiginosis
    ÁøÇ༺ ½É±Ùº´¼º ÈæÀÚÁõ
  • progressive case
    ÁøÇ༺ ¿¹.
  • progressive deafness
    ÁøÇà(¼º) ³­Ã»
  • progressive deafness
    ÁøÇ༺ ³­Ã»(òäú¼àõ Ññôé)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
FFDD focal facial dermal dysplasia
FH facial hemihyperplasia; familial hypercholesterolemia; family history; fasting hyperbilirubinemia; f...
ICF immunodeficiency-centromeric instability-facial anomalies [syndrome]; indirect centrifugal flotation...
LFD lactose-free diet; large for date [fetus]; late fetal death; lateral facial dysplasia; least fatal d...
NAP nasion, point A, pogonion [convexity or concavity of the facial profile]; nerve action potential; ne...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ULO Unilateral ovariectomy
UUO Unilateral uareteral obstruction
UVD Unilateral vestibular deafferentation
RUL right unilateral
UL unilateral
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • atrophy noir
    Èæ»ö À§Ãà
  • correlated atrophy
    »ó°ü À§Ãà, »ó°ü À§ÃàÁõ
  • dental atrophy
    Ä¡¾Æ À§Ãà
    Ä¡¾ÆÀÇ ¿ÜÇüÀÌ Á¤»ó »óź¸´Ù ÁÙ¾îµç °Í.
  • dentate cerebellar atrophy
    Ä¡»ó ÇÙ ¼Ò³ú À§Ãà
    ¼Ò³úÀÇ Ä¡»ó ÇÙÀÌ ÁÙ¾îµå´Â º´¼Ò.
  • diffuse atrophy of alveolar bone
    ¹Ì¸¸¼º Ä¡Á¶°ñ À§Ãà
  • disuse muscle atrophy
    ±ÙÆó¿ë À§Ãà
    ±Ù À§ÃàÀº ¿©·¯ °¡ÁöÀÇ ½Å°æ, ±Ù ÁúȯÀÇ ÁÖ¿ä Áõ»óÀ¸·Î¼­ Áß¿äÇѵ¥ ÀÌ¿Í °°Àº Å»½Å°æ¿¡ ÀÇÇÑ ±Ù À§Ãà À̿ܿ¡µµ ¾ÈÁ¤¿Í»óÀ̳ª °üÀý °íÁ¤ µî¿¡ ÀÇÇÑ ºÎµ¿À¸·Î ¹ß»ýÇÏ´Â ±Ù À§ÃàÀÌ ÀÖ°í ÀüÀÚ¿¡ ¸øÁö ¾Ê°Ô Áß¿äÇÏ´Ù. À̰ÍÀ» Æó¿ë¼º ±Ù À§ÃàÀ̶ó°í ÇÑ´Ù. Àå±â¿Í»ó ȯÀÚ¿¡°Ô À־´Â »óÁö¿¡ ºñÇØ¼­ ÇÏÁöÀÇ ±Ù À§ÃàÀÌ µÎµå·¯Áö°í ÀÌ·± °æÇâÀº °í·ÉÀÚ¿¡°Ô ƯÈ÷ ÇöÀúÇÏ´Ù. ü¿ë¼º ±Ù À§ÃàÀÇ ¹ß»ýÀÌ ¿¹»óµÇ´Â °æ¿ì¿¡´Â ¿¹¹æÀ» À§ÇÑ ±Ù·Â À¯Áö Áõ°­ ÈÆ·ÃÀÌ ÀÌ·ç¾îÁ®¾ß ÇÏ°í ¶Ç Á¶±â ÀÌ»ó, Á¶±â º¸ÇàÀÌ ¸ðµç Áúȯ¿¡¼­ ÃßÁøµÉ Çʿ䰡 ÀÖ´Ù.
  • eccentric atrophy
    ¿ø½É¼º À§Ãà
  • facioscapulohumeral atrophy
    ¾È¸é °ß°© »ó¿Ï À§Ãà, ¾È¸é °ß°© »ó¿Ï±Ù À§Ãà, ¾È¸é °ß°© »ó¿Ï±Ù À§ÃàÁõ
  • hemilingual atrophy
    ÆíÃø ¼³ À§Ãà
    ÇôÀÇ ÁÂÃøÀ̳ª ¿ìÃøÀÇ ÇÑÂÊ¿¡¼­ À§ÃàÀÌ ÀϾ »óÅÂ.
  • hypoplastic atrophy
    ÀúÇü¼º¼º À§Ãà
  • lacunar optic atrophy
    ÇØ¸é ½Ã½Å°æ À§Ãà
  • late cortical cerebelar atrophy
    ¸¸¹ß¼º ÇǺμº ¼Ò³ú À§ÃàÁõ
  • lichen atrophy
    À§Ã༺ ż±
  • muscle atrophy
    ±Ù À§Ãà
  • muscle disuse atrophy
    Æó¿ë¼º ±Ù À§Ãà
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
progressive spinal amyotrophy A serious neurologic disease that results from the progressive degeneration of the motor neurons.
(27 Sep 1997)
progressive staining A procedure in which staining is continued until the desired intensity of colouring of tissue elements is attained.
(05 Mar 2000)
progressive subcortical encephalopathy <radiology> Demyelinating disease due to papovavirus, seen in immunosuppressed hosts: lymphoma, leukaemia, AIDS, TB, sarcoidosis, organ transplant, most prominent in pareito-occipital white matter, NO contrast enhancement
(12 Dec 1998)
progressive supranuclear palsy A disorder that is associated with nerve cell destruction and progressive lack of coordination, neck stiffness, trunk stiffness, problems with eye movement and mild dementia. Disorders that are similar include Alzheimer's disease, cerebellar dysfunction, Jakob-Creutzfeldt disease and Parkinson's disease. The cause for progressive supranuclear palsy is unknown, but is likely a degenerative nerve disorder that is somehow triggered by a viral infection. Pathologic changes include nerve cell damage and destruction of myelin sheath. There is no known cure.
(27 Sep 1997)
progressive tapetochoroidal dystrophy An x chromosome-linked abnormality characterised by atrophy of the choroid and degeneration of the retinal pigment epithelium causing night blindness.
(12 Dec 1998)
progressive torsion spasm A genetic, environmental, or idiopathic disorder, usually beginning in childhood or adolescence, marked by muscular contractions that distort the spine, limbs, hips, and sometimes the cranial-innervated muscles. The abnormal movements are increased by excitement and, at least initially, abolished by sleep. The musculature is hypertonic when in action, hypotonic when at rest. Hereditary forms usually begin with involuntary posturing of the foot or hand (autosomal recessive form ) or of the neck or trunk (autosomal dominant form ); both forms may progress to produce contortions of the entire body.
Synonym: progressive torsion spasm, torsion disease of childhood, torsion dystonia, Ziehen-Oppenheim disease.
(05 Mar 2000)
progressive vaccinia A severe or even fatal form of vaccinia occurring chiefly in subjects with an immunologic deficiency or dyscrasia and characterised by progressive enlargement of the initial and also of secondary lesions.
Synonym: vaccinia gangrenosa.
(05 Mar 2000)
hereditary progressive arthro-ophthalmopathy Autosomal dominant arthro-ophthalmopathy associated with progressive multiple dysplasia of the epiphyses, overtubulation of long bones, cleft lip and palate, hypermobility of joints, flattened vertebral bodies, pelvic bone deformities, and deafness.
Synonym: Stickler's syndrome.
(05 Mar 2000)
supranuclear palsy, progressive A progressive neurological disease usually of the fifth decade characterised by supranuclear ophthalmoplegia especially paralysis of downward gaze, pseudobulbar palsy, gait disturbance, dysathria, truncal dystonia, memory and personality deterioration, and dementia.
(12 Dec 1998)
diaphyseal dysplasia, progressive Progressive thickening of diaphyseal cortex of long bones.
(12 Dec 1998)
ophthalmoplegia, chronic progressive external One of the mitochondrial encephalomyopathies characterised by slowly progressive paralysis of the extraocular muscles. Muscle biopsies disclose the characteristic ragged red fibres and large numbers of mitochondria with deleted DNA.
(12 Dec 1998)
ovine progressive pneumonia A chronic, progressive, contagious interstitial pneumonitis of sheep in Europe and the U.S. Caused by a "slow virus" (family Lentiviridae); it is now believed that maedi and visna are two histopathological and clinical manifestations of the same viral infection.
Synonym: ovine progressive pneumonia.
Origin: Icelandic, dyspnea
(05 Mar 2000)
traumatic progressive encephalopathy A chronic progressive brain damage resulting from multiple brain injuries, e.g., dementia pugilistica.
(05 Mar 2000)
lenticular progressive degeneration <gastroenterology, neurology> An inherited (autosomal recessive) disorder where there is excessive quantities of copper in the tissues, particularly the liver and central nervous system. Wilson's disease causes the body to absorb and retain copper. The copper deposits in the liver, brain, kidneys and eyes. Complications include dementia and liver failure.
Symptoms include jaundice, vomiting, tremors, weakness and slow stiff movements. Blood tests show serum ceruloplasmin is low. Medications are given to remove the excess copper from the body. Even with life-long treatment, disabling (and life-threatening) side effects are common.
Inheritance: autosomal recessive.
(27 Sep 1997)
leukoencephalopathy, progressive multifocal Rare demyelinating disease of the central nervous system which develops in immunocompromised patients secondary to lymphoproliferative disease, immunosuppressive therapy, autoimmune disorders, or aids. It is caused by the jc virus, a polyomavirus.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á